Advances in adrenal tumors 2018

    1. B Skogseid1
    1. 1Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    2. 2Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany
    3. 3Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich, Zürich, Switzerland
    4. 4Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, Bethesda, Maryland, USA
    1. Correspondence should be addressed to J Crona: joakim.crona{at}


    This review aims to provide clinicians and researchers with a condensed update on the most important studies in the field during 2017. We present the academic output measured by active clinical trials and peer-reviewed published manuscripts. The most important and contributory manuscripts were summarized for each diagnostic entity, with a particular focus on manuscripts that describe translational research that have the potential to improve clinical care. Finally, we highlight the importance of collaborations in adrenal tumor research, which allowed for these recent advances and provide structures for future success in this scientific field.

    • Received 19 April 2018
    • Accepted 24 April 2018
    | Table of Contents